Korea’s Yuhan Corporation recently signed a Memorandum of Understanding (MoU) with Walter and Eliza Hall Institute (WEHI) of Medical Research, Australia’s 104-year-old research institutions. The MoU will see Yuhan Corporation and WEHI conduct joint research on early drug development projects in common areas of interest and conduct researcher exchange programs.
WEHI is one of the world’s leading non-profit and non-governmental biomedical research institutes, with major research areas in cancer, immune health and infection, and development and ageing. In addition, a doctor-level researcher’s exchange program will be implemented. The program will provide Yuhan Corporation’s researchers with more in-depth scientific research experience and the WEHI’s researchers with R&D experience in new drugs in industry. Yuhan Corporation established an Australian subsidiary in Adelaide, South Australia, and is planning to diversify joint research and commercialization through the local subsidiary.
